Johnson RW, Alvarez-Pasquin MJ, Bijl M, Franco E, Gaillat J, Clara JG, et al. Herpes zoster epidemiology, management, and disease and economic burden in Europe: a multidisciplinary perspective. Ther Adv Vaccines. 2015;3(4):109–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gauthier A, Breuer J, Carrington D, Martin M, Remy V. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom. Epidemiol Infect. 2009;137(1):38–47.

Article  CAS  PubMed  Google Scholar 

Gabutti G, Bonanni P, Conversano M, Fanelli G, Franco E, Greco D, et al. Prevention of herpes zoster and its complications: from clinical evidence to real life experience. Hum Vaccin Immunother. 2017;13(2):391–8.

Article  PubMed  Google Scholar 

Zhao D, Suo L, Lu L, Pan J, Peng X, Wang Y, et al. Impact of herpes zoster and post-herpetic neuralgia on health-related quality of life in Miyun District of Beijing, China: an EQ-5D survey. Vaccine X. 2023;15: 100415.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen P, Chen Z, Xiao Y, Chen X, Li J, Tang Y, et al. Characteristics and economic burden of hospitalized patients with herpes zoster in China, before vaccination. Hum Vaccin Immunother. 2023;19(3):2268990.

Article  PubMed  PubMed Central  Google Scholar 

Sodergren E, Mardberg K, Nishimwe M, Bhavsar A, Marijam A, Bergstrom T, et al. Incidence and burden of herpes zoster in Sweden: a regional population-based register study. Infect Dis Ther. 2024;13(1):121–40.

Article  PubMed  PubMed Central  Google Scholar 

Chen J, Shin JY, Shantakumar S, Bea S, Ye BD, Lee DG, et al. Burden of herpes zoster in individuals with immunocompromised conditions and autoimmune diseases in the Republic of Korea: a nationwide population-based database study. Infect Dis Ther. 2023;12(12):2771–90.

Article  PubMed  PubMed Central  Google Scholar 

San Martin P, Aunhachoke K, Batac MCF, Lodrono-Lim K, Kwanthitinan C, Santoso D, et al. Systematic literature review of herpes zoster disease burden in Southeast Asia. Infect Dis Ther. 2023;12(6):1553–78.

Article  PubMed  PubMed Central  Google Scholar 

Saguil A, Kane S, Mercado M, Lauters R. Herpes zoster and postherpetic neuralgia: prevention and management. Am Fam Physician. 2017;96(10):656–63.

PubMed  Google Scholar 

Kim JH, Diaz-Decaro J, Jiang N, Hwang SJ, Choo EJ, Co M, et al. The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials. Hum Vaccin Immunother. 2021;17(7):2050–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lal H, Poder A, Campora L, Geeraerts B, Oostvogels L, Vanden Abeele C, et al. Immunogenicity, reactogenicity and safety of 2 doses of an adjuvanted herpes zoster subunit vaccine administered 2, 6 or 12 months apart in older adults: results of a phase III, randomized, open-label, multicenter study. Vaccine. 2018;36(1):148–54.

Article  CAS  PubMed  Google Scholar 

Curran D, Kim JH, Matthews S, Dessart C, Levin MJ, Oostvogels L, et al. Recombinant Zoster vaccine is efficacious and safe in frail individuals. J Am Geriatr Soc. 2021;69(3):744–52.

Article  PubMed  Google Scholar 

Strezova A, Diez-Domingo J, Al Shawafi K, Tinoco JC, Shi M, Pirrotta P, et al. Long-term protection against herpes zoster by the adjuvanted recombinant zoster vaccine: interim efficacy, immunogenicity, and safety results up to 10 years after initial vaccination. Open Forum Infect Dis. 2022;9(10):ofac485.

Article  PubMed  PubMed Central  Google Scholar 

AlMuammar S, Albogmi A, Alzahrani M, Alsharef F, Aljohani R, Aljilani T. Herpes zoster vaccine awareness and acceptance among adults in Saudi Arabia: a survey-based cross-sectional study. Trop Dis Travel Med Vaccines. 2023;9(1):17.

Article  PubMed  PubMed Central  Google Scholar 

Zhang H, Zhang LR, Chu LC, Sun X, Jiang XW. Factors influencing herpes zoster vaccination among older people in China: results from a discrete choice experiment. Public Health. 2023;220:33–4.

Article  CAS  PubMed  Google Scholar 

Lu X, Lu J, Zhang F, Wagner AL, Zhang L, Mei K, et al. Low willingness to vaccinate against herpes zoster in a Chinese metropolis. Hum Vaccin Immunother. 2021;17(11):4163–70.

Article  PubMed  PubMed Central  Google Scholar 

Rui M, Ni H, Xie K, Xu L, Yao M. Progress in radiofrequency therapy for Zoster-associated pain about parameters, modes, targets, and combined therapy: a narrative review. Pain Ther. 2024;13(1):23–32.

Article  PubMed  Google Scholar 

Gruver C, Guthmiller KB. Postherpetic neuralgia. StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Kevin Guthmiller declares no relevant financial relationships with ineligible companies; 2024.

Fan HR, Zhang EM, Fei Y, Huang B, Yao M. Early diagnosis of herpes zoster neuralgia: a narrative review. Pain Ther. 2023;12(4):893–901.

Article  PubMed  PubMed Central  Google Scholar 

Soh H, Ko Y, Shin J, Kim ED. Transforaminal epidural block and erector spinae plane block to manage acute zoster-associated pain: a retrospective case–control study. Medicina (Kaunas). 2024;60(3).

Kim HJ, Ahn HS, Lee JY, Choi SS, Cheong YS, Kwon K, et al. Effects of applying nerve blocks to prevent postherpetic neuralgia in patients with acute herpes zoster: a systematic review and meta-analysis. Korean J Pain. 2017;30(1):3–17.

Article  PubMed  Google Scholar 

Bouhassira D, Chassany O, Gaillat J, Hanslik T, Launay O, Mann C, et al. Patient perspective on herpes zoster and its complications: an observational prospective study in patients aged over 50 years in general practice. Pain. 2012;153(2):342–9.

Article  PubMed  Google Scholar 

Jung BF, Johnson RW, Griffin DR, Dworkin RH. Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology. 2004;62(9):1545–51.

Article  PubMed  Google Scholar 

Opstelten W, Zuithoff NPA, van Essen GA, van Loon AM, van Wijck AJM, Kalkman CJ, et al. Predicting postherpetic neuralgia in elderly primary care patients with herpes zoster: prospective prognostic study. Pain. 2007;132(Suppl 1):S52–9.

Article  PubMed  Google Scholar 

Parruti G, Tontodonati M, Rebuzzi C, Polilli E, Sozio F, Consorte A, et al. Predictors of pain intensity and persistence in a prospective Italian cohort of patients with herpes zoster: relevance of smoking, trauma and antiviral therapy. BMC Med. 2010;8:58.

Article  PubMed  PubMed Central  Google Scholar 

Sankaran R, Kumar A, Parasuram H. Role of artificial intelligence and machine learning in the prediction of the pain: a scoping systematic review. Proc Inst Mech Eng H. 2022;236(10):1478–91.

Article  PubMed  Google Scholar 

Wang XX, Zhang Y, Fan BF. Predicting postherpetic neuralgia in patients with herpes zoster by machine learning: a retrospective study. Pain Ther. 2020;9(2):627–35.

Article  PubMed  PubMed Central  Google Scholar 

Zhang J, Ding Q, Li XL, Hao YW, Yang Y. Support vector machine versus multiple logistic regression for prediction of postherpetic neuralgia in outpatients with herpes zoster. Pain Physician. 2022;25(3):E481–8.

PubMed  Google Scholar 

Gu J, Yuan Y, Wang J, Liu H, Zhang Z, Yan Y. Serum inflammatory cytokine levels in herpes zoster patients and their association with postherpetic neuralgia: a prospective study. Med Sci Monit. 2023;29: e941878.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Werner RN, Nikkels AF, Marinovic B, Schafer M, Czarnecka-Operacz M, Agius AM, et al. European consensus-based (S2k) guideline on the management of herpes zoster—guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: diagnosis. J Eur Acad Dermatol Venereol. 2017;31(1):9–19.

Article  CAS  PubMed  Google Scholar 

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–5.

Article  CAS  PubMed  Google Scholar 

Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP. Validity of four pain intensity rating scales. Pain. 2011;152(10):2399–404.

Article  PubMed  Google Scholar 

Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.

Article  CAS  PubMed  Google Scholar 

Riley RD, Ensor J, Snell KIE, Harrell FE Jr, Martin GP, Reitsma JB, et al. Calculating the sample size required for developing a clinical prediction model. BMJ. 2020;368: m441.

Article  PubMed  Google Scholar 

Zhang Z, Zhao Y, Canes A, Steinberg D, Lyashevska O. Predictive analytics with gradient boosting in clinical medicine. Ann Transl Med. 2019;7(7):152.

Article  PubMed  PubMed Central  Google Scholar 

Deo RC. Machine learning in medicine. Circulation. 2015;132(20):1920–30.

Article  PubMed  PubMed Central  Google Scholar 

Mahalingam R, Gershon A, Gershon M, Cohen JI, Arvin A, Zerboni L, et al. Current in vivo models of Varicella-Zoster virus neurotropism. Viruses. 2019;11(6). https://doi.org/10.3390/v11060502

Seal RP, Wang X, Guan Y, Raja SN, Woodbury CJ, Basbaum AI, et al. Injury-induced mechanical hypersensitivity requires C-low threshold mechanoreceptors. Nature. 2009;462(7273):651–5.

Article  CAS  PubMed  PubMed Central